@keysdiary10's testosterone therapy claims need context

What did @keysdiary10 actually say?

The creator is sharing a personal experience with estrogen therapy, likely in the context of gender-affirming hormone care. They claim that starting estrogen made them "feel less sexually inclined," connecting that shift to mood changes. They also give a strong warning: anyone thinking about having children should bank sperm before starting estrogen, because fertility effects are uncertain and potentially irreversible. Their exact words on this were notably hedged, "you'll still be able to, okay, but it just won't" — which reads like firsthand confusion more than medical misinformation. The advice to seek resources from sperm banks is the most actionable thing they say, and it's worth taking seriously.

This is personal testimony, not a medical lecture. The creator is not claiming to speak for everyone on estrogen — they say "at least for me" at least once. That qualifier matters.

Does the science back this up?

Yes, mostly. The libido claim and the fertility warning both have solid grounding in published research, though the creator understandably simplifies the mechanisms.

On libido: estrogen therapy in transgender women and non-binary individuals is well-documented to reduce sexual desire in a significant subset of patients. A 2017 study by Wierckx et al. in the Journal of Sexual Medicine found that sexual desire decreased substantially in transgender women after cross-sex hormone therapy, and this was one of the most consistently reported changes. The mechanism involves suppression of endogenous testosterone, which drives libido in people assigned male at birth regardless of gender identity. Mood changes, which the creator also mentions, are real and can compound reduced sexual interest.

On fertility: a 2019 review by Hamada et al. in Fertility and Sterility confirmed that exogenous estrogen suppresses the hypothalamic-pituitary-gonadal axis, reducing sperm production. The key issue is that this suppression is not always reversible. Some individuals recover spermatogenesis after stopping hormones; others do not. The creator is right to flag this as urgent. Banking sperm before starting hormone therapy is the current standard recommendation from WPATH and the American Society for Reproductive Medicine.

What did they get wrong (or right)?

They got the core message right. The hesitancy in their delivery, "you'll still be able to, okay, but it just won't," is frustrating to parse but reflects a real clinical ambiguity. Fertility after estrogen therapy is genuinely uncertain, and that uncertainty is not a dodge — it is the medical reality. Pretending there is a clean answer would be worse.

What they got slightly wrong, or at least incomplete: the implication that libido loss is inevitable for everyone. It is common, but not universal. A 2014 study by Elaut et al. in Archives of Sexual Behavior found significant individual variation in sexual functioning among transgender women on hormone therapy. Some people report no meaningful change; others report complete loss of spontaneous desire. The creator says "at least for me," which partially covers this, but a viewer could easily hear their account as a guaranteed outcome.

There is also no mention of timing. Sperm banking ideally happens before the first dose of estrogen, not after months on therapy. That detail is important and missing.

What should you actually know?

If you are starting estrogen and want biological children at any point in the future, sperm banking before your first dose is not optional — it is the only reliable window. Research from Payer et al. (2021, Andrology) found that sperm quality can decline within weeks of starting feminizing hormone therapy, and recovery is not guaranteed even after cessation.

On libido: reduced sexual desire on estrogen is a documented and common experience, but it is not a certainty, and it is not necessarily permanent or static. Some people find it stabilizes. Some find it shifts in character rather than disappearing. A conversation with your prescribing provider before you start is worth having so you know what to watch for and when to flag it.

• WPATH Standards of Care (version 8, 2022) explicitly recommend fertility counseling and gamete preservation discussion before starting gender-affirming hormones.
• Libido changes on estrogen are largely driven by testosterone suppression, not estrogen itself.
• Sperm banking success rates are high when done before starting hormones. That window closes quickly.
• Mood changes and libido changes often occur together early in hormone therapy and may stabilize over time.

Bottom line

This is one person's honest account of what estrogen therapy has been like for them. The libido and fertility claims they make are broadly consistent with the clinical literature. The delivery is messy and incomplete in places, but the core warnings — expect possible desire changes, bank sperm before you start — are the right ones. Give them credit for saying "at least for me" and for pushing people toward actual resources rather than just their own experience.